Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.18K Buy
+215
New +$5.62K ﹤0.01% 248
2025
Q2
Sell
-128
Closed -$3.24K 364
2025
Q1
$3.24K Buy
+128
New +$3.35K ﹤0.01% 320
2024
Q4
Sell
-29,360
Closed -$850K 383
2024
Q3
$850K Buy
29,360
+2,030
+7% +$59.2K 0.04% 158
2024
Q2
$765K Buy
+27,330
New +$752K 0.04% 162

Other funds holding PFE

Aviso Financial's PFE Position: Q2 2026 in Review

Aviso Financial opened a new position in Pfizer (PFE) in Q2 2026: 215 shares worth $5.18K. The stake represents ﹤0.01% of the portfolio and ranks #248 among its holdings. This is a return to the name: Aviso Financial previously reported a position in PFE as recently as Q1 2025.

Aviso Financial first reported a position in PFE in Q2 2024 and has held it in 4 quarters since. The position peaked at $850K in Q3 2024. 2,835 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Aviso Financial held 215 shares of Pfizer worth $5.18K as of Q2 2026.
  • Pfizer was a new Aviso Financial position in Q2 2026.
  • Pfizer made up ﹤0.01% of Aviso Financial's portfolio in Q2 2026, its #248 holding.
  • Aviso Financial first reported a position in Pfizer in Q2 2024 and has held it in 4 quarters since.
  • Aviso Financial's Pfizer position peaked at $850K in Q3 2024.
  • 2,835 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Aviso Financial's 13F filing for Q2 2026, filed 13 Aug 2026.